Our thorough evaluation of the NER protein levels (XPA, XPC, XPF, XPG, ERCC1, and DDB2) and corresponding mRNA levels in various cisplatin-sensitive and -resistant ovarian cancer cell lines revealed that the transcript levels of various NER factors do not accurately reflect their protein levels. This evidence concerns the gene NR1H2 and ovarian carcinoma.